Interferon-β-induced miR-155 inhibits osteoclast differentiation by targeting SOCS1 and MITF.
about
Epigenetic Mechanisms in Bone Biology and Osteoporosis: Can They Drive Therapeutic Choices?MicroRNAs: Potential Biomarkers and Therapeutic Targets for Alveolar Bone Loss in Periodontal DiseaseMicroRNA as Type I Interferon-Regulated Transcripts and Modulators of the Innate Immune ResponseThe role of microRNAs in bone remodelingPost-transcriptional regulation of interferons and their signaling pathwaysBone marrow stroma-derived miRNAs as regulators, biomarkers and therapeutic targets of bone metastasisIdentification of an NF-κB p50/p65-responsive site in the human MIR155HG promoter.MicroRNAs involved in bone formation.NF-κB-direct activation of microRNAs with repressive effects on monocyte-specific genes is critical for osteoclast differentiation.MicroRNA-26a regulates RANKL-induced osteoclast formation.Both MicroRNA-155 and Virus-Encoded MiR-155 Ortholog Regulate TLR3 Expression.The role of microRNAs in osteoclasts and osteoporosis.MicroRNAs' Involvement in Osteoarthritis and the Prospects for Treatments.MicroRNA functions in osteogenesis and dysfunctions in osteoporosisTumor-induced osteoclast miRNA changes as regulators and biomarkers of osteolytic bone metastasis.Cancer-associated osteoclast differentiation takes a good look in the miR(NA)ror.Osteoclastic miR-214 targets TRAF3 to contribute to osteolytic bone metastasis of breast cancer.Transforming Growth Factor β1/Smad4 Signaling Affects Osteoclast Differentiation via Regulation of miR-155 Expression.MicroRNAs as regulators of bone homeostasis and bone metastasis.MicroRNAs in Bone Balance and Osteoporosis.Bone as a Target Organ in Rheumatic Disease: Impact on Osteoclasts and Osteoblasts.MicroRNAs and Periodontal Homeostasis.MicroRNAs in bone diseases.microRNA Expression in Rat Apical Periodontitis Bone Lesion.Identification and Characterization of MicroRNA Differentially Expressed in Macrophages Exposed to Porphyromonas gingivalis Infection.CRISPR/CAS9-Mediated Genome Editing of miRNA-155 Inhibits Proinflammatory Cytokine Production by RAW264.7 Cells.miRNA-340 inhibits osteoclast differentiation via repression of MITFParticipation of MicroRNA-34a and RANKL on bone repair induced by poly(vinylidene-trifluoroethylene)/barium titanate membrane.gga-miR-155 Enhances Type I Interferon Expression and Suppresses Infectious Burse Disease Virus Replication via Targeting SOCS1 and TANK.Enhanced susceptibility of cancer cells to oncolytic rhabdo-virotherapy by expression of Nodamura virus protein B2 as a suppressor of RNA interference.
P2860
Q26741198-C3483C7F-3893-49C4-8B2A-7212DC07B60DQ26741214-1A8BCD76-5AC3-4019-9CEB-E3FE3E668AB3Q26798503-85A78FAB-5DD9-4B82-A3A5-879A000029A8Q26799815-F230847B-FEED-49C5-B054-D5D3EB8CB446Q27014043-533C7685-144B-44A5-B352-9BB35337051FQ28087442-1076ACB1-9387-44FD-8C11-7C402C1734A6Q31140009-8E534F1E-AE44-4DD0-BEF2-7662C9E7380FQ34527129-1AA595E0-26D5-4DBD-8A8C-ADA958221726Q34912673-9B942EFC-C8A3-4C61-82CB-16FA2FF4AC02Q35038986-C1A600A0-16E4-4382-860B-EE96D8C7E926Q35566848-50F160FE-69BB-46AA-8385-CBFD32EE17D6Q36190994-42E76F4E-AC89-489E-A816-B33D3A06A4A9Q36261112-73ECBD46-7638-49F1-B3AB-0B4AD2A492A5Q36917893-63688C8A-9808-45B5-808E-566409C57DC8Q37322289-F7822960-947A-43F3-9211-D34A0A571105Q37498789-FA896421-FC82-4747-AFB8-1D90BB4ADB46Q37575983-3FCE5344-7C5C-45C9-B5D1-D334D126E875Q37746738-B2C1F187-06EC-4091-A458-78A739B81B63Q38239679-4C0C823F-9766-485F-8248-A48D2241881CQ38556136-9DD6EE33-FC28-454A-8155-0532C9840FA3Q38593977-9A7F22AA-D020-4D9E-BBD3-43B7D2258748Q38772841-FF8CCC10-6B05-4FB8-B74F-2AF01D8F3214Q39025218-3A8BF2FC-329E-47D5-8715-04826B0ADF8FQ39410557-D39B4340-E6C5-4711-BBA4-92A2B538BF56Q40378814-86E3F6BF-558D-47CF-A55B-7079334EDA0CQ41872391-FC13E241-7149-48EF-AAB5-B96423E50543Q42334830-5146C432-0872-48A8-933B-2FA3F153250CQ53079563-F9BEE394-5C3D-472B-9374-444B950900E8Q55057344-7D4E7DF2-1D32-4CE2-A248-D280881BDC2DQ55309857-1E3BB964-D617-4D82-9EA2-1074EE4CBF50
P2860
Interferon-β-induced miR-155 inhibits osteoclast differentiation by targeting SOCS1 and MITF.
description
2012 nî lūn-bûn
@nan
2012年の論文
@ja
2012年学术文章
@wuu
2012年学术文章
@zh-cn
2012年学术文章
@zh-hans
2012年学术文章
@zh-my
2012年学术文章
@zh-sg
2012年學術文章
@yue
2012年學術文章
@zh
2012年學術文章
@zh-hant
name
Interferon-β-induced miR-155 i ...... n by targeting SOCS1 and MITF.
@en
Interferon-β-induced miR-155 i ...... n by targeting SOCS1 and MITF.
@nl
type
label
Interferon-β-induced miR-155 i ...... n by targeting SOCS1 and MITF.
@en
Interferon-β-induced miR-155 i ...... n by targeting SOCS1 and MITF.
@nl
prefLabel
Interferon-β-induced miR-155 i ...... n by targeting SOCS1 and MITF.
@en
Interferon-β-induced miR-155 i ...... n by targeting SOCS1 and MITF.
@nl
P2093
P2860
P1433
P1476
Interferon-β-induced miR-155 i ...... n by targeting SOCS1 and MITF.
@en
P2093
Hongying Zhao
Jianjian Shen
Jinping Chen
Yazeng Huang
Yongming Jin
P2860
P304
P356
10.1016/J.FEBSLET.2012.06.047
P407
P577
2012-07-04T00:00:00Z